Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,180 | -23,321 | -18,088 | -16,562 | -10,207 |
| Depreciation Amortization | 891 | 788 | 687 | 655 | 303 |
| Accounts payable and accrued liabilities | 843 | -909 | 637 | -528 | -271 |
| Other Working Capital | 104 | -1,171 | 1,907 | -258 | -165 |
| Other Operating Activity | 3,524 | 4,142 | 1,908 | 3,423 | 1,200 |
| Operating Cash Flow | $-25,818 | $-20,471 | $-12,949 | $-13,270 | $-9,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,386 | -1,273 | -281 | -2,932 | -1,403 |
| Purchase Of Investment | N/A | N/A | N/A | -277 | -142 |
| Other Investing Activity | 1,245 | 996 | -221 | 500 | 0 |
| Investing Cash Flow | $-141 | $-277 | $-502 | $-2,709 | $-1,545 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 456 | N/A | 1,100 | N/A |
| Debt Repayment | -66 | -122 | -126 | -68 | -9 |
| Common Stock Issued | 67,215 | 1,285 | 37,574 | 2,082 | 15 |
| Common Stock Repurchased | 0 | -4 | 13 | -468 | N/A |
| Other Financing Activity | -149 | -107 | 4,908 | 8,688 | 19,620 |
| Financing Cash Flow | $67,000 | $1,508 | $42,369 | $11,334 | $19,626 |
| Beginning Cash Position | 20,250 | 39,490 | 10,572 | 15,217 | 6,276 |
| End Cash Position | 61,291 | 20,250 | 39,490 | 10,572 | 15,217 |
| Net Cash Flow | $41,041 | $-19,240 | $28,918 | $-4,645 | $8,941 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,818 | -20,471 | -12,949 | -13,270 | -9,140 |
| Capital Expenditure | -1,386 | -1,323 | -281 | -2,932 | -1,403 |
| Free Cash Flow | -27,204 | -21,794 | -13,230 | -16,202 | -10,543 |